Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04919993 · ClinicalTrials.gov registry record · NA
CBT for Insomnia in Primary Brain Tumor Patients
A NA study of Primary Brain Tumor and PBT, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT04919993: Completed NA study of Primary Brain Tumor and PBT, sponsored by Virginia Commonwealth University.
NCT04919993 is a NA study of Primary Brain Tumor and PBT that has completed, run by Virginia Commonwealth University. The registered enrollment target is 44 participants, below the 79-participant average among 7 other Primary Brain Tumor trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04919993, a NA study of Primary Brain Tumor and PBT, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot test an empirically supported psychotherapeutic intervention, Cognitive Behavior Therapy for Insomnia (CBT-I) in primary brain tumor patients. Researchers hope to better understand the feasibility and acceptability of this intervention in neuro-oncology, as well as the preliminary potential benefits of this intervention on brain tumor patients' sleep, fatigue, mood, quality of life, and chronic inflammation. This may lead to improvements in treating insomnia in primary brain tumor patients.
Primary Outcome
Determine how many patients consent to screening after referral to the program, how many patients are eligible for the program after being screened, and how many consent/enroll in the program if eligible.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy-Insomnia
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-08-15 |
| Phase | NA |
What the finished NCT04919993 record still lists
NCT04919993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 79-participant average among 7 other Primary Brain Tumor trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Primary Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy-Insomnia is the first listed.
NCT04919993 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04919993 about?
NCT04919993 is a clinical study titled "CBT for Insomnia in Primary Brain Tumor Patients". The purpose of this study is to pilot test an empirically supported psychotherapeutic intervention, Cognitive Behavior Therapy for Insomnia (CBT-I) in primary brain tumor patients. Researchers hope to better understand the feasibility and acceptability of this intervention in neuro-oncology, as well...
What is the current status of trial NCT04919993?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-06-01. Estimated completion is 2022-08-15.
What conditions does trial NCT04919993 study?
This clinical trial studies the following conditions: Primary Brain Tumor, PBT.
What interventions are being tested in trial NCT04919993?
The interventions under investigation include: Cognitive Behavioral Therapy-Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT04919993?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04919993 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Glioma Characterization Through Molecular Imaging
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
RECRUITING
-
Assessment of Eloquent Function in Brain Tumor Patients
RECRUITING
-
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
RECRUITING · Phase 1
-
Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI